Abnormal expression of GLI2 promotes carcinogenesis by enhancing cell growth and regulating stem cell self-renewal, making it a potential therapeutic target for treating cancer or increasing the effectiveness of chemotherapy [8, 27]. The gene discussed is GLI2; the disease is cancer.